Literature DB >> 20425071

HDL lipids and insulin resistance.

Andrew N Hoofnagle1, Tomas Vaisar, Poulami Mitra, Alan Chait.   

Abstract

There is renewed interest in high-density lipoproteins (HDLs) due to recent findings linking atherosclerosis to the formation of dysfunctional HDL. This article focuses on the universe of HDL lipids and their potential protective or proinflammatory roles in vascular disease and insulin resistance. HDL carries a wide array of lipids including sterols, triglycerides, fat-soluble vitamins, and a large number of phospholipids, including phosphatidylcholine, sphingomyelin, and ceramide with many biological functions. Ceramide has been implicated in the pathogenesis of insulin resistance and has many proinflammatory properties. In contrast, sphingosine-1-phosphate, which is transported mainly in HDL, has anti-inflammatory properties that may be atheroprotective and may account for some of the beneficial effects of HDL. However, the complexity of the HDL lipidome is only beginning to reveal itself. The emergence of new analytical technologies should rapidly increase our understanding of the function of HDL lipids and their role in disease states.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20425071     DOI: 10.1007/s11892-009-0085-7

Source DB:  PubMed          Journal:  Curr Diab Rep        ISSN: 1534-4827            Impact factor:   4.810


  75 in total

1.  Lipophilic antioxidants and polyunsaturated fatty acids in lipoprotein classes: distribution and interaction.

Authors:  V H Sunesen; C Weber; G Hølmer
Journal:  Eur J Clin Nutr       Date:  2001-02       Impact factor: 4.016

Review 2.  High density lipoproteins and atherosclerosis.

Authors:  G J Miller
Journal:  Annu Rev Med       Date:  1980       Impact factor: 13.739

3.  Sphingosine-1 phosphate prevents monocyte/endothelial interactions in type 1 diabetic NOD mice through activation of the S1P1 receptor.

Authors:  Angela M Whetzel; David T Bolick; Suseela Srinivasan; Timothy L Macdonald; Margaret A Morris; Klaus Ley; Catherine C Hedrick
Journal:  Circ Res       Date:  2006-09-07       Impact factor: 17.367

4.  Characterization of phospholipids in pre-alpha HDL: selective phospholipid efflux with apolipoprotein A-I.

Authors:  W Zhang; B Asztalos; P S Roheim; L Wong
Journal:  J Lipid Res       Date:  1998-08       Impact factor: 5.922

Review 5.  The role of dysfunctional HDL in atherosclerosis.

Authors:  Mohamad Navab; Srinivasa T Reddy; Brian J Van Lenten; G M Anantharamaiah; Alan M Fogelman
Journal:  J Lipid Res       Date:  2008-10-27       Impact factor: 5.922

6.  Differential distribution of sphingomyelins among plasma lipoprotein classes.

Authors:  J J Myher; A Kuksis; W C Breckenridge; J A Little
Journal:  Can J Biochem       Date:  1981-08

7.  Aggregated low density lipoprotein induces tissue factor by inhibiting sphingomyelinase activity in human vascular smooth muscle cells.

Authors:  S Camino-López; L Badimon; A González; D Canals; E Peña; V Llorente-Cortés
Journal:  J Thromb Haemost       Date:  2009-10-08       Impact factor: 5.824

8.  Promotion of lymphocyte egress into blood and lymph by distinct sources of sphingosine-1-phosphate.

Authors:  Rajita Pappu; Susan R Schwab; Ivo Cornelissen; João P Pereira; Jean B Regard; Ying Xu; Eric Camerer; Yao-Wu Zheng; Yong Huang; Jason G Cyster; Shaun R Coughlin
Journal:  Science       Date:  2007-03-15       Impact factor: 47.728

Review 9.  Lipoprotein-associated estrogens.

Authors:  Matti J Tikkanen; Veera Vihma; Matti Jauhiainen; Anna Höckerstedt; Hannamaarit Helisten; Maija Kaamanen
Journal:  Cardiovasc Res       Date:  2002-11       Impact factor: 10.787

10.  Lipoprotein electrostatic properties regulate hepatic lipase association and activity.

Authors:  Jonathan G Boucher; Trang Nguyen; Daniel L Sparks
Journal:  Biochem Cell Biol       Date:  2007-12       Impact factor: 3.626

View more
  12 in total

Review 1.  HDL cholesterol and bone mineral density: is there a genetic link?

Authors:  Cheryl L Ackert-Bicknell
Journal:  Bone       Date:  2012-02       Impact factor: 4.398

2.  Anthropometric variables, physical activity and dietary intakes of patients with uric acid nephrolithiasis.

Authors:  Alberto Trinchieri; Emanuele Croppi; Giovanni Simonelli; Carmine Sciorio; Emanuele Montanari
Journal:  Urolithiasis       Date:  2019-04-29       Impact factor: 3.436

3.  Low clusterin levels in high-density lipoprotein associate with insulin resistance, obesity, and dyslipoproteinemia.

Authors:  Andrew N Hoofnagle; Mingyuan Wu; Albina K Gosmanova; Jessica O Becker; Ellen M Wijsman; John D Brunzell; Steven E Kahn; Robert H Knopp; Timothy J Lyons; Jay W Heinecke
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-09-16       Impact factor: 8.311

4.  Dyslipidemia is associated with an increased risk of nephrolithiasis.

Authors:  James H Masterson; Jason R Woo; David C Chang; Thomas Chi; James O L'Esperance; Marshall L Stoller; Roger L Sur
Journal:  Urolithiasis       Date:  2014-09-06       Impact factor: 3.436

Review 5.  Gene-activation mechanisms in the regression of atherosclerosis, elimination of diabetes type 2, and prevention of dementia.

Authors:  P V Luoma
Journal:  Curr Mol Med       Date:  2011-07       Impact factor: 2.222

6.  Effects of n-3 polyunsaturated fatty acids high fat diet intervention on the synthesis of hepatic high-density lipoprotein cholesterol in obesity-insulin resistance rats.

Authors:  Xianxing Xie; Tao Zhang; Shuang Zhao; Wei Li; Lanzhi Ma; Ming Ding; Yuan Liu
Journal:  Lipids Health Dis       Date:  2016-04-22       Impact factor: 3.876

7.  Impact of dyslipidemia on 24-h urine composition in adults without urolithiasis.

Authors:  Chao Cai; Zanlin Mai; Tuo Deng; Zhijian Zhao; Wei Zhu; Yaoan Wen; Xiaolu Duan; Wenqi Wu; Guohua Zeng
Journal:  Lipids Health Dis       Date:  2018-11-06       Impact factor: 3.876

Review 8.  Sphingomyelin in high-density lipoproteins: structural role and biological function.

Authors:  Roberto Martínez-Beamonte; Jose M Lou-Bonafonte; María V Martínez-Gracia; Jesús Osada
Journal:  Int J Mol Sci       Date:  2013-04-09       Impact factor: 5.923

9.  Type 2 diabetes is associated with loss of HDL endothelium protective functions.

Authors:  Tomáš Vaisar; Erica Couzens; Arnold Hwang; Michael Russell; Carolyn E Barlow; Laura F DeFina; Andrew N Hoofnagle; Francis Kim
Journal:  PLoS One       Date:  2018-03-15       Impact factor: 3.240

10.  Metabolic phenotyping by treatment modality in obese women with gestational diabetes suggests diverse pathophysiology: An exploratory study.

Authors:  Sara L White; Shahina Begum; Matias C Vieira; Paul Seed; Deborah L Lawlor; Naveed Sattar; Scott M Nelson; Paul Welsh; Dharmintra Pasupathy; Lucilla Poston
Journal:  PLoS One       Date:  2020-04-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.